Daptomycin vs Gramicidin A — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Daptomycin (Cubicin) is a cyclic lipopeptide antibiotic from Streptomyces roseosporus, FDA-approved in 2003. It has a novel mechanism of action distinct from all other approved antibiotics: calcium-dependent insertion into bacterial membranes followed by channel formation and rap...
Calculate Daptomycin dose →Gramicidin A is a 15-residue linear peptide antibiotic from Bacillus brevis, distinct from the cyclic gramicidin S despite sharing the same producer organism. Gramicidin A is the active component in Neosporin and other topical antibiotic combinations....
Calculate Gramicidin A dose →| Parameter | Daptomycin | Gramicidin A |
|---|---|---|
| Category | Antimicrobial Peptide | Antimicrobial Peptide |
| Research | FDA Approved | Approved (topical combination) |
| Half-Life | 8-9 hours | Hours (membrane-bound) |
| Typical Dose | 4-6 mg/kg IV once daily (skin); 6-10 mg/kg IV once daily (bacteremia) | Component of Neosporin and similar products |
| Frequency | Once daily IV | As needed |
| Route | IV | Topical (combination products) |
| FDA Status | Approved (MRSA skin, bacteremia, right-sided endocarditis, 2003) | Approved (topical combination) |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.